跳至主要内容
临床试验/CTRI/2020/01/022808
CTRI/2020/01/022808尚未招募不适用

Visual and refractive outcomes and patient satisfaction real world evaluation following bilateral implantation of AcrySof IQ PanOptixToric IOL

NETHRADHAMA SUPER SPECIALITY EYE HOSPITAL BANGALORE1 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2020年1月20日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
33
试验地点
1
主要终点
Primary Endpoint: 3 Months post 2nd eye Surgery:-

研究概览

简要总结

Aprospective, interventional, non-randomized, single centre study to to characterize the visual outcomes of PanOptixToric Multifocal IOLimplanted to replace the natural lens in cataract patients. Trial population shall comprise of adult Indian subjects 18-70 years ofage at the time of informed consent with no ocular pathology with regularcorneal topography and corneal astigmatism from 0.75 D to 4.00 D who requirecataract extraction. 33 subjects fulfilling the inclusion and exclusioncriteria undergoing bilateral implantation of  PanOptixToric IOL implantation (n=66)following cataract surgery to be performed by a single surgeon at NethradhamaSuper Speciality Eye Hospital, will be included in the study to provide real world evidence on visual and refractive outcomes, and patientsatisfaction.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Regular corneal topography and corneal astigmatism from 0.75 D to 4.00 D.
  • Best Corrected Visual Acuity to be 0.2 LogMAR or lower
  • Clear intraocular media
  • Availability, willingness and sufficient cognitive awareness to comply with examination procedures.

排除标准

  • Any active ocular disease
  • Diabetic retinopathy, retinal degenerative disorders, macular degeneration, glaucoma with field defects
  • Irregular corneal astigmatism( keratoconus/ PMD)
  • Previous intraocular and corneal refractive surgery
  • Pregnancy & Lactation
  • Traumatic , Intumescent and white Cataracts
  • Subject who have retinal pathologies or dystrophies and those who are expected to require retinal laser treatment
  • Concurrent participation in another drug or device study.

结局指标

主要结局

Primary Endpoint: 3 Months post 2nd eye Surgery:-

时间窗: Pre-opertative/ intra-opera visits and post-operative days 1, 15, 90, 180, 365

Corrected photopic distance visual acuity (CDVA, binocular)

时间窗: Pre-opertative/ intra-opera visits and post-operative days 1, 15, 90, 180, 365

次要结局

  • 1. Uncorrected and corrected photopic distance, intermediate and near visual acuity(2. Improvement in Quality of Life (Quality of Life Questionnaire developed by Rasch Analysis))

研究者

发起方
NETHRADHAMA SUPER SPECIALITY EYE HOSPITAL BANGALORE
申办方类型
Private hospital/clinic

研究点 (1)

Loading locations...

相似试验